Suppr超能文献

直线加速器立体定向放射外科治疗颅内海绵状畸形的预后因素分析

Prognostic Factors Analysis for Intracranial Cavernous Malformations Treated with Linear Accelerator Stereotactic Radiosurgery.

作者信息

Chung Meng-Wu, Chuang Chi-Cheng, Wang Chun-Chieh, Chen Hsien-Chih, Hsu Peng-Wei

机构信息

Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan 333, Taiwan.

Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan 333, Taiwan.

出版信息

Life (Basel). 2022 Aug 31;12(9):1363. doi: 10.3390/life12091363.

Abstract

Stereotactic radiosurgery (SRS) is generally considered a substitute for cranial cavernous malformations (CCMs). However, prognostic factors for post-radiosurgery CCM rebleeding and adverse radiation effects have not been well evaluated, and the effect of timing and optimal treatment remains controversial. Therefore, this study evaluated prognostic factors for post-radiosurgical rebleeding and focal edematous changes in 30 patients who developed symptomatic intracranial hemorrhage due to solitary non-brainstem CCM and received linear accelerator (LINAC) SRS in a single medical center from October 2002 to June 2018. An overall post-radiosurgical annual hemorrhage rate with 4.5% was determined in this study. In addition, a higher marginal dose of >1600 centigray and earlier LINAC SRS intervention were correlated with a significantly lower post-radiosurgical annual hemorrhage rate. A lesion size larger than 3 cm3 and a coexisting developmental venous anomaly were significant risk factors for post-radiosurgical focal brain edema but mostly resulted in no symptoms and were temporary. This study demonstrated the efficacy of LINAC SRS in preventing CCM rebleeding and suggests that earlier radiosurgery treatment with a higher dose for non-brainstem symptomatic CCMs be considered.

摘要

立体定向放射外科手术(SRS)通常被认为是治疗颅内海绵状血管畸形(CCM)的一种替代方法。然而,放射外科手术后CCM再出血和不良放射效应的预后因素尚未得到充分评估,治疗时机和最佳治疗方法的效果仍存在争议。因此,本研究评估了2002年10月至2018年6月期间在单一医疗中心因孤立性非脑干CCM发生症状性颅内出血并接受直线加速器(LINAC)SRS治疗的30例患者放射外科手术后再出血和局灶性水肿变化的预后因素。本研究确定放射外科手术后的总体年出血率为4.5%。此外,较高的边缘剂量>1600厘戈瑞和更早的LINAC SRS干预与放射外科手术后显著较低的年出血率相关。大于3 cm³的病变大小和并存的发育性静脉异常是放射外科手术后局灶性脑水肿的重要危险因素,但大多无症状且为暂时性。本研究证明了LINAC SRS在预防CCM再出血方面的有效性,并建议考虑对非脑干症状性CCM进行更高剂量的早期放射外科治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a12/9505264/3629a10cb722/life-12-01363-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验